Christophe Couturier Insider Profile

11 Followers
Christophe Couturier, Chief Financial Officer at Tempest Therapeutics, holds 73.93K shares in Avantor (Ticker: AVTR), holds 600.00 shares in Tempest Therapeutics (Ticker: TPST).
tipranks
Christophe Couturier

Christophe Couturier
Tempest Therapeutics (TPST)
Chief Financial Officer

Ranked #42,827 out of 99,218 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+3.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
99.97%
0.03%
A breakdown of Christophe Couturier's holdings

Insider Roles

Avantor
(AVTR)
EVP, AMEA
Tempest Therapeutics
(TPST)
Chief Financial Officer
Roles that Christophe Couturier holds in companies

Most Profitable Insider Trade

Stock:
Avantor
(AVTR)
Rating:Informative Sell
Date:Aug 01, 2024 - Today
Return:+15.80%
The most profitable trade made by Christophe Couturier

Christophe Couturier's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Tempest Therapeutics
Mar 13, 2017
Chief Financial Officer
Uninformative Buy
429.00
$545.40
Avantor
Aug 01, 2024
EVP, AMEA
Uninformative Sell
270.00K
$1.65M
List of latest transactions for each holding click on a transaction to see Christophe Couturier's performance on stock

Christophe Couturier insider profile FAQ

What is the percentage of profitable transactions made by Christophe Couturier?
The percentage of profitable transactions made by Christophe Couturier is 67%.
    What is the average return per transaction made by Christophe Couturier?
    The average return per transaction made by Christophe Couturier is 3.40%.
      What stocks does Christophe Couturier hold?
      Christophe Couturier holds: TPST, AVTR stocks.
        What was Christophe Couturier’s latest transaction?
        Christophe Couturier latest transaction was an Uninformative Sell of $270.00K.
          What was Christophe Couturier's most profitable transaction?
          Christophe Couturier’s most profitable transaction was an Informative Sell of AVTR stock on August 1, 2024. The return on the trade was 15.80%.
            What is Christophe Couturier's role in Tempest Therapeutics?
            Christophe Couturier's role in Tempest Therapeutics is Chief Financial Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.